TY - JOUR AU - Ligresti, G. AU - Militello, L. AU - Steelman, L. S. AU - Cavallaro, A. AU - Basile, F. AU - Nicoletti, F. PY - 2009 DA - 2009// TI - PIK3CA mutations in human solid tumors: role in sensitivity to various therapeutic approaches JO - Cell Cycle VL - 8 UR - https://doi.org/10.4161/cc.8.9.8255 DO - 10.4161/cc.8.9.8255 ID - Ligresti2009 ER - TY - JOUR AU - Carpten, J. D. AU - Faber, A. L. AU - Horn, C. AU - Donoho, G. P. AU - Briggs, S. L. AU - Robbins, C. M. PY - 2007 DA - 2007// TI - A transforming mutation in the pleckstrin homology domain of AKT1 in cancer JO - Nature VL - 448 UR - https://doi.org/10.1038/nature05933 DO - 10.1038/nature05933 ID - Carpten2007 ER - TY - JOUR AU - Turner, N. AU - Grose, R. PY - 2010 DA - 2010// TI - Fibroblast growth factor signalling: from development to cancer JO - Nat Rev Cancer VL - 10 UR - https://doi.org/10.1038/nrc2780 DO - 10.1038/nrc2780 ID - Turner2010 ER - TY - JOUR AU - Lieu, C. AU - Heymach, J. AU - Overman, M. AU - Tran, H. AU - Kopetz, S. PY - 2011 DA - 2011// TI - Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-0659 DO - 10.1158/1078-0432.CCR-11-0659 ID - Lieu2011 ER - TY - JOUR AU - Dienstmann, R. AU - Rodon, J. AU - Prat, A. AU - Perez-Garcia, J. AU - Adamo, B. AU - Felip, E. PY - 2014 DA - 2014// TI - Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdt419 DO - 10.1093/annonc/mdt419 ID - Dienstmann2014 ER - TY - JOUR AU - Welcsh, P. L. AU - Owens, K. N. AU - King, M. C. PY - 2000 DA - 2000// TI - Insights into the functions of BRCA1 and BRCA2 JO - Trends Genet VL - 16 UR - https://doi.org/10.1016/S0168-9525(99)01930-7 DO - 10.1016/S0168-9525(99)01930-7 ID - Welcsh2000 ER - TY - JOUR AU - Li, H. AU - Durbin, R. PY - 2009 DA - 2009// TI - Fast and accurate short read alignment with Burrows-Wheeler transform JO - Bioinformatics VL - 25 UR - https://doi.org/10.1093/bioinformatics/btp324 DO - 10.1093/bioinformatics/btp324 ID - Li2009 ER - TY - JOUR AU - Li, H. AU - Durbin, R. PY - 2010 DA - 2010// TI - Fast and accurate long-read alignment with Burrows-Wheeler transform JO - Bioinformatics VL - 26 UR - https://doi.org/10.1093/bioinformatics/btp698 DO - 10.1093/bioinformatics/btp698 ID - Li2010 ER - TY - JOUR AU - Robinson, J. T. AU - Thorvaldsdóttir, H. AU - Winckler, W. AU - Guttman, M. AU - Lander, E. S. AU - Getz, G. PY - 2011 DA - 2011// TI - Integrative genomics viewer JO - Nat Biotechnol VL - 29 UR - https://doi.org/10.1038/nbt.1754 DO - 10.1038/nbt.1754 ID - Robinson2011 ER - TY - JOUR AU - Wang, K. AU - Li, M. AU - Hakonarson, H. PY - 2010 DA - 2010// TI - ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data JO - Nucleic Acids Res VL - 38 UR - https://doi.org/10.1093/nar/gkq603 DO - 10.1093/nar/gkq603 ID - Wang2010 ER - TY - JOUR AU - Forbes, S. A. AU - Bindal, N. AU - Bamford, S. AU - Cole, C. AU - Kok, C. Y. AU - Beare, D. PY - 2011 DA - 2011// TI - COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer JO - Nucleic Acids Res VL - 39 UR - https://doi.org/10.1093/nar/gkq929 DO - 10.1093/nar/gkq929 ID - Forbes2011 ER - TY - STD TI - 1000 genomes browsers. http://www.1000genomes.org. Accessed 17 Oct 2016. UR - http://www.1000genomes.org/ ID - ref12 ER - TY - STD TI - NHLBI Exome Sequencing Project (ESP). Exome Variant Server. http://evs.gs.washington.edu/EVS/. UR - http://evs.gs.washington.edu/EVS/ ID - ref13 ER - TY - STD TI - Human Genetic Variation. http://www.genome.med.kyoto-u.ac.jp/SnpDB. UR - http://www.genome.med.kyoto-u.ac.jp/SnpDB ID - ref14 ER - TY - JOUR AU - Eisenhauer, E. A. AU - Therasse, P. AU - Bogaerts, J. AU - Schwartz, L. H. AU - Sargent, D. AU - Ford, R. PY - 2009 DA - 2009// TI - New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2008.10.026 DO - 10.1016/j.ejca.2008.10.026 ID - Eisenhauer2009 ER - TY - JOUR AU - Tourneau, C. AU - Delord, J. P. AU - Gonçalves, A. AU - Gavoille, C. AU - Dubot, C. AU - Isambert, N. PY - 2015 DA - 2015// TI - Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)00188-6 DO - 10.1016/S1470-2045(15)00188-6 ID - Tourneau2015 ER - TY - JOUR AU - André, F. AU - Bachelot, F. AU - Commo, F. AU - Campone, M. AU - Arnedos, M. AU - Dieras, V. PY - 2014 DA - 2014// TI - Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER) JO - Lancet Oncol VL - 15 UR - https://doi.org/10.1016/S1470-2045(13)70611-9 DO - 10.1016/S1470-2045(13)70611-9 ID - André2014 ER - TY - STD TI - Estey E, Hoth D, Simon R, Marsoni S, Leyland-Jones B, Wittes R. Therapeutic response in phase I trials of antineoplastic agents. Cancer Treat Rep. 1986;70(9):1105–15. Accessed 17 Oct 2016. ID - ref18 ER - TY - STD TI - Horstmann E, McCabe M, Grochow L, Yamamoto S, Rubinstein L, Budd T, et al. Risks and benefits of phase 1 oncology trials, 1991 through 2002. N Engl J Med. 2005;352(9):895–904. Accessed 17 Oct 2016. ID - ref19 ER - TY - STD TI - Smith TL, Lee JJ, Kantarjian H, Legha SS, Raber MN. Design and results of phase I cancer clinical trials: three-year experience at M.D. Anderson Cancer Center. J Clin Oncol. 1996;14(1):287–95. Accessed 17 Oct 2016. ID - ref20 ER - TY - JOUR AU - Sekine, I. AU - Yamamoto, N. AU - Kunitoh, H. AU - Ohe, Y. AU - Tamura, T. AU - Kodama, T. PY - 2002 DA - 2002// TI - Relationship between objective responses in phase I trials and potential efficacy of non-specific cytotoxic investigational new drugs JO - Ann Oncol VL - 13 UR - https://doi.org/10.1093/annonc/mdf202 DO - 10.1093/annonc/mdf202 ID - Sekine2002 ER -